400
Participants
Start Date
December 14, 2020
Primary Completion Date
August 1, 2023
Study Completion Date
January 25, 2024
Non-interventional
Non-interventional, subjects will only have routine testing (blood biomarkers, spirometry, peak inspiratory flow measurements) and be asked to complete questionnaires.
University Hospital Sassari, Sassari
Mater Dei Hospital, Valletta
Changi General Hospital, Singapore
Singapore General Hospital, Singapore
Ljubljana University Medical Centre, Ljubljana
Hanyang University Guri Hospital, Hanyang
Seoul St. Mary's Hospital, Seoul
Ulsan University Hospital, Ulsan
Hospital University de Torrecárdenas, Almería
University Hospital Vall d'Hebron, Barcelona
Hospital Inmaculada HLA, Granada
HU Virgen de las Nieves, Granada
Hospital Universitario de La Ribera, Valencia
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Respiratory Effectiveness Group
OTHER